secwatch.observer — SEC 8-K summary
======================================

Issuer:     ILLUMINA, INC. (ILMN)
CIK:        0001110803
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001110803-26-000014
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Illumina completes $350M acquisition of SomaLogic from Standard BioTools
------------------------------------------------------------------------

- Purchase price $350M in cash plus up to $75M in performance milestones and royalties.
- SomaLogic's proteomics tech (SomaScan, SomaSignal) expands Illumina's multiomics portfolio.
- Acquisition funded with cash on hand; financial impact discussed on Feb 5, 2026 earnings call.
- Builds on co-development partnership established in 2021 for NGS-based proteomics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1110803/000111080326000014/0001110803-26-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1110803/000111080326000014/ilmn-20260130.htm
  HTML page:      https://secwatch.observer/filing/0001110803-26-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer